Global Recombinant Human Follicle-stimulating Hormone Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 101

Published Date: 30 Aug 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Recombinant Human Follicle-stimulating Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Recombinant Human Follicle-stimulating Hormone market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Recombinant Human Follicle-stimulating Hormone market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Infertility Treatment occupied for % of the Recombinant Human Follicle-stimulating Hormone global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, 75IU segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Recombinant Human Follicle-stimulating Hormone include Merck, Ferring, Livzon, Gedeon Richter and GenSci, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Recombinant Human Follicle-stimulating Hormone market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.

Main Recombinant Human Follicle-stimulating Hormone companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Recombinant Human Follicle-stimulating Hormone market based on the following parameters – headquarters, products portfolio, Recombinant Human Follicle-stimulating Hormone revenue and gross margin, recent developments.

Evaluation and forecast the Recombinant Human Follicle-stimulating Hormone market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Recombinant Human Follicle-stimulating Hormone market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
    75IU
    150IU
    Others

Market segment by Application (2017-2028; USD Million)
    Infertility Treatment
    Assisted Reproductive Technology

The key market players for global Recombinant Human Follicle-stimulating Hormone market are listed below:
    Merck
    Ferring
    Livzon
    Gedeon Richter
    GenSci
    Teva
    ChangChun High & New Technology
    ABL
    Scripps Laboratories
    Alphamab Oncology
    Hunan Jingfeng Pharmaceutical
    Qilu Pharmaceutical
    Beijing SL Pharmaceutical

Region Segment (2017-2028; USD Million)
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
    South America (Brazil, Argentina, Colombia and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Recombinant Human Follicle-stimulating Hormone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Recombinant Human Follicle-stimulating Hormone, with revenue, gross margin and global market share of Recombinant Human Follicle-stimulating Hormone from 2019 to 2022.
Chapter 3, the Recombinant Human Follicle-stimulating Hormone competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Human Follicle-stimulating Hormone market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Recombinant Human Follicle-stimulating Hormone research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Recombinant Human Follicle-stimulating Hormone
    1.2 Classification of Recombinant Human Follicle-stimulating Hormone by Type
        1.2.1 Overview: Global Recombinant Human Follicle-stimulating Hormone Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type in 2021
        1.2.3 75IU
        1.2.4 150IU
        1.2.5 Others
    1.3 Global Recombinant Human Follicle-stimulating Hormone Market by Application
        1.3.1 Overview: Global Recombinant Human Follicle-stimulating Hormone Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Infertility Treatment
        1.3.3 Assisted Reproductive Technology
    1.4 Global Recombinant Human Follicle-stimulating Hormone Market Size & Forecast
    1.5 Global Recombinant Human Follicle-stimulating Hormone Market Size and Forecast by Region
        1.5.1 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region, (2017-2022)
        1.5.3 North America Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2017-2028)
        1.5.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2017-2028)
        1.5.6 South America Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Recombinant Human Follicle-stimulating Hormone Market Drivers
        1.6.2 Recombinant Human Follicle-stimulating Hormone Market Restraints
        1.6.3 Recombinant Human Follicle-stimulating Hormone Trends Analysis

2 Company Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Merck Recent Developments and Future Plans
    2.2 Ferring
        2.2.1 Ferring Details
        2.2.2 Ferring Major Business
        2.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Ferring Recent Developments and Future Plans
    2.3 Livzon
        2.3.1 Livzon Details
        2.3.2 Livzon Major Business
        2.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Livzon Recent Developments and Future Plans
    2.4 Gedeon Richter
        2.4.1 Gedeon Richter Details
        2.4.2 Gedeon Richter Major Business
        2.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Gedeon Richter Recent Developments and Future Plans
    2.5 GenSci
        2.5.1 GenSci Details
        2.5.2 GenSci Major Business
        2.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 GenSci Recent Developments and Future Plans
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Teva Recent Developments and Future Plans
    2.7 ChangChun High & New Technology
        2.7.1 ChangChun High & New Technology Details
        2.7.2 ChangChun High & New Technology Major Business
        2.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 ChangChun High & New Technology Recent Developments and Future Plans
    2.8 ABL
        2.8.1 ABL Details
        2.8.2 ABL Major Business
        2.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 ABL Recent Developments and Future Plans
    2.9 Scripps Laboratories
        2.9.1 Scripps Laboratories Details
        2.9.2 Scripps Laboratories Major Business
        2.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Scripps Laboratories Recent Developments and Future Plans
    2.10 Alphamab Oncology
        2.10.1 Alphamab Oncology Details
        2.10.2 Alphamab Oncology Major Business
        2.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Alphamab Oncology Recent Developments and Future Plans
    2.11 Hunan Jingfeng Pharmaceutical
        2.11.1 Hunan Jingfeng Pharmaceutical Details
        2.11.2 Hunan Jingfeng Pharmaceutical Major Business
        2.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Hunan Jingfeng Pharmaceutical Recent Developments and Future Plans
    2.12 Qilu Pharmaceutical
        2.12.1 Qilu Pharmaceutical Details
        2.12.2 Qilu Pharmaceutical Major Business
        2.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Qilu Pharmaceutical Recent Developments and Future Plans
    2.13 Beijing SL Pharmaceutical
        2.13.1 Beijing SL Pharmaceutical Details
        2.13.2 Beijing SL Pharmaceutical Major Business
        2.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
        2.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Beijing SL Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Recombinant Human Follicle-stimulating Hormone Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Recombinant Human Follicle-stimulating Hormone Players Market Share in 2021
        3.2.2 Top 10 Recombinant Human Follicle-stimulating Hormone Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Recombinant Human Follicle-stimulating Hormone Players Head Office, Products and Services Provided
    3.4 Recombinant Human Follicle-stimulating Hormone Mergers & Acquisitions
    3.5 Recombinant Human Follicle-stimulating Hormone New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Recombinant Human Follicle-stimulating Hormone Revenue and Market Share by Type (2017-2022)
    4.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2017-2022)
    5.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2028)
    6.2 North America Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2028)
    6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country
        6.3.1 North America Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2028)
        6.3.2 United States Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        6.3.3 Canada Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        6.3.4 Mexico Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2028)
    7.2 Europe Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2028)
    7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country
        7.3.1 Europe Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2028)
        7.3.2 Germany Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        7.3.3 France Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        7.3.5 Russia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        7.3.6 Italy Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2028)
    8.2 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2028)
    8.3 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region
        8.3.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Region (2017-2028)
        8.3.2 China Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        8.3.3 Japan Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        8.3.4 South Korea Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        8.3.5 India Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        8.3.7 Australia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2028)
    9.2 South America Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2028)
    9.3 South America Recombinant Human Follicle-stimulating Hormone Market Size by Country
        9.3.1 South America Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2028)
        9.3.2 Brazil Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        9.3.3 Argentina Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2028)
    10.2 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2028)
    10.3 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country
        10.3.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2028)
        10.3.2 Turkey Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)
        10.3.4 UAE Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Human Follicle-stimulating Hormone Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Recombinant Human Follicle-stimulating Hormone Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region (2023-2028)
    Table 6. Merck Corporate Information, Head Office, and Major Competitors
    Table 7. Merck Major Business
    Table 8. Merck Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 9. Merck Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Ferring Corporate Information, Head Office, and Major Competitors
    Table 11. Ferring Major Business
    Table 12. Ferring Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 13. Ferring Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Livzon Corporate Information, Head Office, and Major Competitors
    Table 15. Livzon Major Business
    Table 16. Livzon Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 17. Livzon Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Gedeon Richter Corporate Information, Head Office, and Major Competitors
    Table 19. Gedeon Richter Major Business
    Table 20. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 21. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. GenSci Corporate Information, Head Office, and Major Competitors
    Table 23. GenSci Major Business
    Table 24. GenSci Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 25. GenSci Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Teva Corporate Information, Head Office, and Major Competitors
    Table 27. Teva Major Business
    Table 28. Teva Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 29. Teva Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. ChangChun High & New Technology Corporate Information, Head Office, and Major Competitors
    Table 31. ChangChun High & New Technology Major Business
    Table 32. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 33. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. ABL Corporate Information, Head Office, and Major Competitors
    Table 35. ABL Major Business
    Table 36. ABL Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 37. ABL Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Scripps Laboratories Corporate Information, Head Office, and Major Competitors
    Table 39. Scripps Laboratories Major Business
    Table 40. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 41. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Alphamab Oncology Corporate Information, Head Office, and Major Competitors
    Table 43. Alphamab Oncology Major Business
    Table 44. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 45. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Hunan Jingfeng Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 47. Hunan Jingfeng Pharmaceutical Major Business
    Table 48. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 49. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Qilu Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 51. Qilu Pharmaceutical Major Business
    Table 52. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 53. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Beijing SL Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 55. Beijing SL Pharmaceutical Major Business
    Table 56. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
    Table 57. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Global Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 59. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 60. Breakdown of Recombinant Human Follicle-stimulating Hormone by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 61. Recombinant Human Follicle-stimulating Hormone Players Head Office, Products and Services Provided
    Table 62. Recombinant Human Follicle-stimulating Hormone Mergers & Acquisitions in the Past Five Years
    Table 63. Recombinant Human Follicle-stimulating Hormone New Entrants and Expansion Plans
    Table 64. Global Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) by Type (2017-2022)
    Table 65. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Type (2017-2022)
    Table 66. Global Recombinant Human Follicle-stimulating Hormone Revenue Forecast by Type (2023-2028)
    Table 67. Global Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2022)
    Table 68. Global Recombinant Human Follicle-stimulating Hormone Revenue Forecast by Application (2023-2028)
    Table 69. North America Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2022) & (USD Million)
    Table 70. North America Recombinant Human Follicle-stimulating Hormone Revenue by Type (2023-2028) & (USD Million)
    Table 71. North America Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2022) & (USD Million)
    Table 72. North America Recombinant Human Follicle-stimulating Hormone Revenue by Application (2023-2028) & (USD Million)
    Table 73. North America Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 74. North America Recombinant Human Follicle-stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 75. Europe Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2022) & (USD Million)
    Table 76. Europe Recombinant Human Follicle-stimulating Hormone Revenue by Type (2023-2028) & (USD Million)
    Table 77. Europe Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2022) & (USD Million)
    Table 78. Europe Recombinant Human Follicle-stimulating Hormone Revenue by Application (2023-2028) & (USD Million)
    Table 79. Europe Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 80. Europe Recombinant Human Follicle-stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 81. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2022) & (USD Million)
    Table 82. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Type (2023-2028) & (USD Million)
    Table 83. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2022) & (USD Million)
    Table 84. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Application (2023-2028) & (USD Million)
    Table 85. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Region (2017-2022) & (USD Million)
    Table 86. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue by Region (2023-2028) & (USD Million)
    Table 87. South America Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2022) & (USD Million)
    Table 88. South America Recombinant Human Follicle-stimulating Hormone Revenue by Type (2023-2028) & (USD Million)
    Table 89. South America Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2022) & (USD Million)
    Table 90. South America Recombinant Human Follicle-stimulating Hormone Revenue by Application (2023-2028) & (USD Million)
    Table 91. South America Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 92. South America Recombinant Human Follicle-stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 93. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Type (2017-2022) & (USD Million)
    Table 94. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Type (2023-2028) & (USD Million)
    Table 95. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Application (2017-2022) & (USD Million)
    Table 96. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Application (2023-2028) & (USD Million)
    Table 97. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 98. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Recombinant Human Follicle-stimulating Hormone Picture
    Figure 2. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type in 2021
    Figure 3. 75IU
    Figure 4. 150IU
    Figure 5. Others
    Figure 6. Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application in 2021
    Figure 7. Infertility Treatment Picture
    Figure 8. Assisted Reproductive Technology Picture
    Figure 9. Global Recombinant Human Follicle-stimulating Hormone Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 10. Global Recombinant Human Follicle-stimulating Hormone Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 12. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region in 2021
    Figure 13. North America Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 14. Europe Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 15. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. South America Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Recombinant Human Follicle-stimulating Hormone Market Drivers
    Figure 19. Recombinant Human Follicle-stimulating Hormone Market Restraints
    Figure 20. Recombinant Human Follicle-stimulating Hormone Market Trends
    Figure 21. Merck Recent Developments and Future Plans
    Figure 22. Ferring Recent Developments and Future Plans
    Figure 23. Livzon Recent Developments and Future Plans
    Figure 24. Gedeon Richter Recent Developments and Future Plans
    Figure 25. GenSci Recent Developments and Future Plans
    Figure 26. Teva Recent Developments and Future Plans
    Figure 27. ChangChun High & New Technology Recent Developments and Future Plans
    Figure 28. ABL Recent Developments and Future Plans
    Figure 29. Scripps Laboratories Recent Developments and Future Plans
    Figure 30. Alphamab Oncology Recent Developments and Future Plans
    Figure 31. Hunan Jingfeng Pharmaceutical Recent Developments and Future Plans
    Figure 32. Qilu Pharmaceutical Recent Developments and Future Plans
    Figure 33. Beijing SL Pharmaceutical Recent Developments and Future Plans
    Figure 34. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Players in 2021
    Figure 35. Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 36. Global Top 3 Players Recombinant Human Follicle-stimulating Hormone Revenue Market Share in 2021
    Figure 37. Global Top 10 Players Recombinant Human Follicle-stimulating Hormone Revenue Market Share in 2021
    Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 39. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Type in 2021
    Figure 40. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Type (2023-2028)
    Figure 41. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Application in 2021
    Figure 42. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Application (2023-2028)
    Figure 43. North America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 44. North America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 45. North America Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 46. United States Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Canada Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Mexico Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Europe Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 50. Europe Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 51. Europe Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 52. Germany Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. France Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. United Kingdom Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Russia Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Italy Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 58. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 59. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 60. China Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Japan Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South Korea Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. India Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Southeast Asia Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Australia Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. South America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 67. South America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 68. South America Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 69. Brazil Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Argentina Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 72. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 73. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 74. Turkey Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. UAE Recombinant Human Follicle-stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical

Product Tags

recombinant human follicle stimulating hormone

Recombinant Human Follicle-stimulating Hormone

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>